Author Aly-Khan Lalani talks to editor Mike Leveridge about the evolution of treatment of metastatic renal cell carcinoma.
Subscribers can access Aly-Khan’s eLearning module The evolution of metastatic kidney cancer treatment: from interferons to the novel immunotherapies.